Elizabeth Trehu, Chief Medical Officer at Jounce Therapeutics, Inc. (JNCE), sold 13,500 shares at $10.09 ($136K) on 2021-03-29, disclosed to the SEC on 2021-03-31.
Open-market sale of $136k JNCE by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.09 | 5,100 | $51K | 37.8% |
| 2 | $10.00 | 100 | $1K | 0.7% |
| 3 | $10.09 | 8,300 | $84K | 61.5% |
| Total | $10.09 avg | 13,500 | $136K | 100% |
| Filing → |
| JNCE | SELL | 2021-01-22 | $78K | — | Filing → |
| JNCE | SELL | 2021-01-11 | $36K | — | Filing → |
| JNCE | SELL | 2020-08-18 | $10K | — | Filing → |